MoonLake Immunotherapeutics Cash Flow Statement (2021-2026) | MLTX

Cash Flow Statement Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
-32.69M-6.29M-53.64M-15.88M-17.42M-14.74M-16.47M-12.22M-12.35M-11.62M-7.89M-13.97M-24.76M-36.11M-46.40M-40.56M-56.05M-70.69M-63.02M-69.71M
Depreciation and Depletion (Quarter)
0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.02M0.03M0.03M
Share-based Compensation (Quarter)
1.86M9.05M1.99M2.48M2.59M2.60M2.58M1.50M1.43M1.61M1.68M1.83M1.84M1.93M2.29M3.31M3.71M3.59M13.36M
Gains from Investment Securities (Quarter)
-0.01M-0.00M-0.02M0.03M0.43M-0.10M-0.01M0.01M3.73M0.23M-0.12M1.33M-1.21M0.59M-0.42M
Cash from Operations (Quarter)
-25.60M-2.02M-35.18M-14.19M-20.76M-9.35M-11.60M-9.02M-12.16M-9.25M-12.34M-14.95M-27.89M-25.28M-48.47M-38.14M-54.53M-44.54M-58.79M-66.29M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF) (Quarter)
0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.33M0.34M0.33M0.39M0.40M0.72M0.74M0.75M0.80M
Change in Working Capital
Change in Receivables (Quarter)
0.06M0.15M0.43M-0.02M0.04M-0.38M0.16M0.24M0.10M0.34M0.44M0.18M0.73M0.44M0.15M0.42M0.61M0.85M0.89M
Change in Account Payables (Quarter)
0.21M1.57M2.25M-3.03M0.27M-0.80M3.57M0.53M-0.96M-1.57M1.65M1.66M5.57M-1.72M3.01M5.07M8.20M4.27M-6.17M
Change in Accured Expenses (Quarter)
0.74M2.10M4.51M-1.35M-0.11M1.90M2.24M-3.95M-0.67M1.42M2.87M-2.81M1.69M2.11M4.17M-1.56M-1.81M12.86M-6.90M7.12M
Other Working Capital Changes (Quarter)
0.04M-0.00M1.45M0.85M2.82M-0.63M-3.18M-1.10M0.88M0.10M-0.10M0.83M-1.56M8.25M5.37M-0.27M-0.17M-0.40M-0.38M-0.39M
Investing Activities
Capital Expenditures (Quarter)
0.01M0.05M0.02M-2.001.000.28M0.21M0.13M0.18M0.04M
Change in Acquisitions & Divestments (Quarter)
9.90M19.65M12.68M1.36M117.15M59.12M-1.30M87.59M-0.21M144.83M205.91M88.40M29.26M59.17M
Cash from Investing Activities (Quarter)
-0.01M-0.05M-0.02M2.00-42.23M9.90M19.65M12.68M-174.38M116.87M-28.80M-87.74M58.28M-147.33M56.25M88.25M88.40M-29.91M0.10M
Financing Activities
Other financing activities (Quarter)
101.00M
Cash from Financing Activities (Quarter)
27.82M0.50M43.26M15.00M104.69M0.00M451.29M28.42M50.98M0.18M0.15M73.12M0.48M72.39M30.64M
Additional items
Exchange Rate Effect (Quarter)
-0.00M0.00M-0.01M-0.05M0.07M-0.01M-535.00-0.14M0.01M0.06M0.05M-0.02M-0.33M0.42M-0.09M1.39M-0.28M0.09M-0.48M
Change in Cash (Quarter)
2.21M-1.53M8.04M0.80M83.87M-51.50M-1.70M10.62M451.66M-183.62M133.00M7.27M-115.65M32.86M-195.23M91.14M35.12M44.05M-16.22M-36.03M
Free Cash Flow (Quarter)
-25.60M-2.03M-35.23M-14.20M-20.76M-9.35M-11.60M-9.02M-12.16M-9.25M-12.63M-15.16M-27.89M-25.41M-48.65M-38.17M-54.53M-44.54M-58.79M-66.29M
Net Cash Flow (Quarter)
2.23M-1.53M8.04M0.80M83.92M-51.58M-1.69M10.62M451.80M-183.63M132.94M7.23M-115.63M33.19M-195.65M91.23M33.72M44.34M-16.31M-35.54M